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MicroRNAs (miRNAs) are known to play important roles in liver regeneration, although the role of
miRNAs associated with the termination of liver regeneration is not as well studied. Here we
reported the down-regulation of miR-23b in the termination stage of liver regeneration in rats. In
addition, Smad3 was identiﬁed as a target of miR-23b during liver regeneration. Up-regulation of
miR-23b promoted BRL-3A cell proliferation and partially inhibited transforming growth factor
(TGF)-b1-induced apoptosis. Furthermore, TGF-b1 transcriptionally inhibited miR-23b expression.
We conclude that down-regulation of miR-23b may contribute to activation of the TGF-b1/Smad3
signalling pathway during the termination stage of liver regeneration.
 2011 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Following 70% partial hepatectomy (PHx), the remnant liver has
a remarkable ability to regenerate to its original mass and function
within 7–10 days after surgery in a process called liver regenera-
tion (LR) [1–3]. LR after PHx is generally divided into three distinct
phases: initiation, proliferation and termination [4,5]. Despite mul-
tiple studies of LR, many aspects of this phenomenon remain un-
known, including the proper temporal regulation of termination.
MicroRNAs (miRNAs) are a class of small regulatory RNAs that
silence messenger RNAs by binding to their 30-untranslated regions
(UTRs). miRNAs have been reported to modulate a variety of bio-
logical processes, including cellular differentiation and prolifera-
tion, metabolism and apoptosis [6–8]. It is reported that miRNAs
(miR-21 and miR-378) play critical roles during the early phases
of LR by directly inhibiting the expression of target genes that asso-
ciate with DNA synthesis [9,10]. However, the miRNAs that func-
tion in the termination stage of LR remain unknown.
In a preliminary study using a miRNA microarray analysis,
we found that miRNA 23b (miR-23b) was down-regulated inon behalf of the Federation of Euro
ghuaJiao@126.com (B. Jiao).
k.regenerating rat liver tissues 120 h (h) after 70% PHx compared
to the sham operation (SH) group (sham operation, rats underwent
abdominal surgery without liver resection). MiR-23b has been re-
ported to be involved in many cell functions including cell prolifer-
ation, migration and differentiation [11–14]. And a recent study
has shown that miR-23b served as a molecular switch in regulating
Transforming growth factor-b1 (TGF-b1) signaling by targeting
Smads [15]. Considering the noteworthy role TGF-b1 plays during
the termination stage of LR, the present work sought to elucidate
if and how miR-23b was involved in the termination stage of LR.
We also report evidences that miR-23b expression is remarkably
diminished during the termination of LR, and miR-23b may con-
tribute to the TGF-b1/Smad3 signalling pathway during the termi-
nation stage of LR.2. Materials and methods
2.1. Animals and operative procedure
Adult male Sprague–Dawley rats (180–210 g) were randomly
assigned to two groups (20 animals in each group) as follows: (i)
PH group, animals were subjected to 70% partial hepatectomy
(PHx) under sodium pentobarbital (50 mg/kg, intraperitoneally)pean Biochemical Societies.
Fig. 1. Down-regulation of miR-23b during the termination stage of LR. The
expression of miR-23b in the regenerating liver from 24 to 168 h after partial
hepatectomy assessed by quantitative real-time PCR analysis. MiR-23b levels were
standardised to that of u6. All data were obtained from at least three independent
experiments and are shown as the means ± S.E., ⁄P < 0.05, ⁄⁄P < 0.01.
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without liver resection. The animals in each group were further di-
vided into 4 sub-groups (24, 72, 120 and 168 h (h), n = 5). At the
indicated time points: 24, 72, 120, 168 h after surgery, the animals
were sacriﬁced and the remnant liver tissues were collected. All
experiments were performed in accordance with the Institutional
Animal Care Instructions approved by the Ethics Committee for
Animal, Second Military Medical University.
2.2. Reverse transcription and quantitative real-time PCR
Total RNA was isolated from prepared liver samples using
TRIzol (Invitrogen, Carlsbad) reagent and cDNA was synthesised
following the manufacturer’s protocol (MBI Fermentas). Quantita-
tive real-time PCR (qRT-PCR) was performed using a standard SYBR
green PCR kit (TOYOBO), and PCR-speciﬁc ampliﬁcation was ap-
plied in the Applied Biosystems (ABI7300) real-time PCR machine.
The relative expression of genes (mir-23b, u6, Smad3, Smad4,
Smad5 and actin) was calculated with the 2DDCt method. Primers
are listed in S.I. Table 1.
2.3. Cell culture and transient transfection
An established rat liver cell line, BRL-3A, was obtained from the
Institute of Biochemistry and Cell Biology (Shanghai, China). BRL-
3A cells were grown in DMEM (GIBCO) supplemented with 10%
foetal bovine serum (FBS; GIBCO) in a humidiﬁed atmosphere con-
taining 5% CO2 at 37 C. MiR-23b mimics, inhibitor and their corre-
sponding negative control (NC) sequences were obtained from
GenePharma (Shanghai, China). Transfections were performed
using Lipofectamine 2000 reagent (Invitrogen) according to the
manufacturer’s instructions.
2.4. Cell proliferation assay by methylthiazoletetrazolium
BRL-3A cells were transfected with miR-23b mimics or inhibitor
or the corresponding NC, (GenePharma) in the 24-well plate and
were re-seeded in 96-well plates at a density of 2000 cells per well
for 48 h after transfection. At the indicated time points (24, 48, 72,
96 h) after re-seeding in 96-well plates, 20 lL methylthiazoletet-
razolium (MTT) solution (5 mg/mL) was added to the culture med-
ium and incubated for 4 h. The reaction was terminated with the
addition of 150 lL dimethyl sulfoxide (DMSO) to each well to dis-
solve the crystals. The absorbance of each sample was recorded at
570 nm 10 min after the addition of DMSO.
2.5. Cell cycle analysis by ﬂow cytometry
BRL-3A cells cultured in 6-well plates were treated with miR-
23b inhibitor or NC. Forty-eight hours later, cells were collected,
ﬁxed with 70% ethanol for 30 min and then washed with ice-cold
PBS. The cells were spun down and resuspended using RNase-con-
taining (1:100 in dilution) PBS on ice prior to staining with propi-
dium iodide (PI) and analysis using a ﬂow cytometer.
2.6. Cell apoptosis analysis by ﬂow cytometry
BRL-3A cells were cultured in 6-well plates and transfected
with miR-23b mimics, or NC. Twenty-four hours post-transfection,
BRL-3A cells were treated with TGF-b1 (R&D) (5 ng/ml) for 6 h and
24 h. The cells were then collected for apoptotic analysis by ﬂow
cytometry. An annexin V detection kit was employed to determine
apoptotic cells according to the manufacturer’s instructions. Data
acquisition and analysis were performed using a FACSort Cytome-
ter (FACSCA, USA). For each analysis, 1  105 cells were scanned.
Each experiment was repeated at least three times.2.7. Vector construction
The 30UTR of wild type Smad3 containing the Smad3-miR-23b
response element, as well as the mutant 30UTR of Smad3, were syn-
thesised by PCR. The resulting PCR amplicons were cloned into the
XhoI/FseI sites of the pGL3 basic Luciferase vector separately (Pro-
mega). Primers are listed in S.I. Table 2.
For the miR-23b promoter assay, a 1000-bp genomic fragment
upstream of the transcriptional start site of miR-23b precursor
was ampliﬁed by PCR. Then the resulting amplicon was cloned into
the HindIII/XhoI sites of the pGL3 control Luciferase vector (Prome-
ga). Primers are listed in S.I. Table 2.
2.8. Luciferase reporter assay
BRL-3A cells were seeded in a 24-well plate (1  105 per well)
and transfected with Smad3-UTR-pGL3/Mu-Smad3-UTR-pGL3
(200 ng), Renilla luciferase control vector (20 ng) and miR-23b/NC
(150 pmol). Forty-eight hours later, all protein extracts were ana-
lysed using the dual luciferase reporter assay system (Promega).
2.9. Western blot analysis
For whole protein extracts, liver tissue or cell samples were
homogenised in lysis buffer (Promega), incubated for 30 min on
ice, then centrifuged for 15 min at 12 000g. Prior to use, all buf-
fers were treated with a protease inhibitor cocktail (Konchem, Chi-
na). Equal amounts of protein were separated discontinuously on
12–15% SDS–PAGE and transferred to a nitrocellulose membrane
(Amersham Pharmacia, UK). The antibodies used included anti-
Smad3, phosphorylated Smad3 (Cell Signalling Technology, MA,
USA), anti-Smad4, Smad5 (Epitomics, Burlingame, CA), anti-Actin
(Sigma). Immunoblots were developed using anti-mouse- or anti-
rabbit-HRP secondary antibodies (Proteintech Group), followed
by detection with enhanced chemiluminescence (Pierce, Biotech-
nology) performed according to the manufacturer’s instructions.
2.10. Immunohistochemical staining and evaluation
Rat liver tissues were collected at the indicated time points (24,
72, 120 and 168 h) after PHx or SH, and ﬁxed with formalin,
embedded with parafﬁn. Proliferating cell nuclear antigen (PCNA)
analysis was performed using the labelled streptavidin biotin
(LSAB) method. Samples were ﬁrst incubated with an anti-PCNA
antibody (Cell Signaling Technology, MA, USA), and then with a
biotinylated secondary antibody (ChemMate ENVISION). All
stained sections were examined under a light microscope at a
magniﬁcation of 400. The PCNA index corresponds to the number
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section. Terminal deoxynucleotidyl transferase-mediated dUTP
nick end labelling (TUNEL) was performed using an in situ apopto-
sis detection kit (Roche). TUNEL-positive cells were counted in ﬁve
random high power (400) ﬁelds and are expressed as the number
of cells per ﬁeld. The TUNEL index corresponds to the number of
positively stained cells/total number of cells counted in each
section.
2.11. Determination of caspase activity
Caspase-3 activity was determined using a caspase ﬂuorometric
assay kit (Bio-Vision), according to the manufacturer’s protocol.
The ﬂuorescence responses were recorded every ﬁve minutes for
1 h using a FlexStationII microplate reader (Molecular Devices Cor-
poration; California, USA) at 37 C. Excitation and emission wave-
lengths were 400 and 505 nm, respectively. The relative contentFig. 2. MiR-23b modulates rat liver cells growth. (A and B) BRL-3A cells were transfect
proliferation was examined at the indicated time points by methylthiazoletetrazolium. Th
after staining. (C and D) Cells treated with miR-2b inhibitor or its negative control (15
analysis as described in the materials and methods. All data were obtained from at le
⁄⁄P < 0.01.of activated enzymes in a sample was expressed as RFU (relative
ﬂuorescence unit) according to the slope of the enzymatic reaction
curve.
2.12. Statistical analysis
The data are shown as the means ± S.E. of three experiments.
Statistical signiﬁcance was estimated with a Student’s t-test for un-
paired observations. A P-value of less than 0.05 was considered to
be signiﬁcant.
3. Results
3.1. Down-regulation of miR-23b during the termination stage of LR
We utilised qRT-PCR to measure the mRNA expression of miR-
23b during LR at the above-mentioned time points. As shown ined with either miR-23b mimics or inhibitor or NC (150 pmol), and the relative cell
e absorbance of methylthiazoletetrazolium by each sample was recorded at 570 nm
0 pmol) were analysed by ﬂuorescence-activated cells sorting (FACS) for cell cycle
ast three independent experiments and are shown as the means ± S.E., ⁄P < 0.05,
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LR after PHx, as observed in the regenerating rat liver compared
to the SH control. This difference was especially prominent at
120 h after PHx, where miR-23b expression showed a 5-fold reduc-
tion compared with SH (P < 0.01) (Fig. 1).
3.2. MiR-23b modulate BRL-3A cell growth
To evaluate the effect of miR-23b in regulating rat liver cell
growth, a MTT cell proliferation assay was used as described previ-
ously Brieﬂy, BRL-3A immortalised rat liver cells were transfected
with miR-23b mimics or NC, miR-23b inhibitor or NC. MTT assays
were performed at 96 h intervals. As shown in Fig. 2A, miR-23b
mimics markedly promoted BRL-3A cell growth at 48 h (P < 0.05),
while miR-23b inhibitor inhibited BRL-3A cell growth compared
with NC, especially at 96 h (P < 0.05) (Fig. 2B). Cell cycle analysis
showed that the percentages of miR-23b and NC cells in the G2
phase of the cell cycle were 26.9 ± 6.12% and 12.53 ± 4.78%, respec-
tively, indicating a subpopulation of cells arrested in G2 phase by
miR-23b inhibitor (Fig. 2C and D).
3.3. Smad3 but not Smad4 or Smad5 is a gene target of miR-23b
Although the mechanism of LR termination remains obscure,
some important signalling pathways have been linked to this pro-
cess, including TGF-b1 and activin-A [16–18]. Therefore, we
hypothesise that miR-23b may be linked to LR termination
through these pathways by the target genes associated with them.Fig. 3. Smad3 is a target gene of miR-23b. (A) miR-23b decreases the mRNA expression o
actin was used as the sample control. (B) miR-23b down-regulates protein expression o
used as the loading control. (C) miR-23b-binding sites in the 30 UTR (top) and mutated
binding sites in the 30 UTR of Smad3. Smad3-Mu1-UTR and Smad3-Mu2-UTR were two m
that aimed at both of the two-binding sites. (D) The 30 UTR of Smad3 mediates Sma
containing the 30 UTR or mutated sequence of Smad3 (Smad3-Mu1-UTR, Smad3-Mu2
150 pmol in 24-well plate. The PGL3 control vector was used as a control. ⁄⁄P < 0.01.Smads (Smad3, Smad4 and Smad5), which are downstream pro-
teins of TGF-b1 signalling, have been reported to be the target
genes of miR-23b in murine fetal liver stem cells (HBC-3 cells)
[15,19]. However, results from our real-time PCR and western blot
analysis revealed that with treatment of miR-23b mimics
(150 pmol in 24-well plate) in BRL-3A cells, Smad3 expression
notably decreased in both mRNA and protein level; Smad4
showed no apparent change; Smad5 mRNA expression showed a
signiﬁcant increase, while Smad5 protein expression had no alter-
ations (Fig. 3A and B). These results suggest that Smad3 but not
Smad4 or Smad5 is a major target gene of miR-23b in BRL-3A
cells. To assess whether the regulation of Smad3 is direct, we
fused the 30UTR region of Smad3 to a luciferase reporter to vali-
date the effects of miR-23b mimics on wild type and mutant plas-
mids (Fig. 3C). Mutations in seed complementary sites fully
rescued repression of Smad3 (Fig. 3D).
3.4. Up-regulation of miR-23b partially inhibits TGF-b1 induced
apoptosis by targeting Smad3
To investigate the relationship between miR-23b and the TGF-
b1/Smad3 signalling pathway, we initially transfected BRL-3A cells
with miR-23b mimics or NC, and then treated the transfected cells
with TGF-b1 (R&D) (5 ng/ml) 48 h later. Using ﬂow cytometry we
determined that treatment of TGF-b1 for 24 h resulted in a
13.4 ± 1.91% of apoptosis of BRL-3A cells that have been transfec-
ted with miR-23b mimics compared to 31.7 ± 3.83% of apoptotic
cells in the NC group (Fig. 4A and B). Western blot analysisf Smad3 by qRT-PCR analysis. The mRNA expression of Smad5 was increased. Beta-
f Smad3, while Smad4 and Smad5 protein show no obvious change. Beta-actin was
sites in 30 UTR (bottom) of Smad3 in a luciferase reporter. There are two miR-23b
utants aimed at the two-binding sites separately, Smad3-Mu(1,2)-UTR was a mutant
d3 repression. BRL-3A cells were co-transfected with a luciferase reporter vector
-UTR, Smad3-Mu(1,2)-UTR) 200 ng and miR-23b mimics or negative control (NC)
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reduced in the miR-23b mimetic group compared to the NC group
(Fig. 4C). These results suggest that up-regulation of miR-23b par-
tially inhibited TGF-b1-induced apoptosis in BRL-3A cells by inhib-
iting the expression of Smad3.
3.5. Down-regulation of miR-23b may contribute to activation of the
TGF-b1/Smad3 signalling pathway during the termination stage of LR
We have investigated the expression of Smad3 in the regenerat-
ing liver at 24, 72 120, 168 h after PHx or SH by real-time RT-PCR
and western blot analysis. We observed a highly signiﬁcant up-reg-
ulation of both Smad3 mRNA and protein levels in the regenerating
liver in PHx rats. The inverse expression of miR-23b and Smad3 in
the regenerating liver suggests that Smad3 was a target of miR-23b
during the termination stage of LR. An increased expression of
phosphorylated Smad3 was also observed by western blot analysis
(Fig. 5A and B). Using PCNA, TUNEL and caspase-3 activity assays
we have found that compared with the SH group, the PHx group
showed an increased apoptotic activity and a decreased prolifera-Fig. 4. Up-regulation of Smad3 partially inhibits TGF-b1 induced apoptosis. (A and B) BR
TGF-b1 for 6 and 24 h, and cell apoptosis was analysed by ﬂuorescence-activated cells so
of Smad3 and phosphorylated Smad3. Actin was used as the loading control. All data w
means ± S.E., ⁄P < 0.05, ⁄⁄P < 0.01.tive activity from 72 to 168 h after PHx (Fig. 5C–F). Taken together,
down-regulation of miR-23b may contribute to activation of the
TGF-b1/Smad3 signalling pathway during the termination stage
of LR.
3.6. TGF-b1 inhibits the expression of miR-23b at the transcriptional
level
To examine whether TGF-b1 is the upstream regulator of miR-
23b, we treated BRL-3A cells with different concentrations of
TGF-b1 (0–5 ng/ml), and found a negative correlation between
TGF-b1 and miR-23b expression (Fig. 6A). To investigate whether
TGF-b1 regulates the expression of miR-23b at the transcriptional
level, we used the promoter region (1040-bp upstream of the tran-
scriptional start site of miR-23b) to drive the expression of a lucif-
erase reporter gene in BRL-3A cells. Treatment of TGF-b1 (5 ng/ml)
led to an inhibition of miR-23b promoter activity (Fig. 6B), indicat-
ing that this promoter region recapitulated expression of the miR-
23b gene. In summary, we found that TGF-b1 inhibits miR-23b
expression at the transcriptional level.L-3A cells transfected with miR-2b mimics or its negative control were treated with
rting (FACS) as described in Section 2. (C) miR-23b decreased the protein expression
ere obtained from at least three independent experiments and are shown as the
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Recent studies have shown that miRNAs, which mediate post-
transcriptional gene silencing, are involved in the proliferation
stage of LR [9,10]. However, the miRNAs that associate with the
termination of LR have rarely been reported. Our preliminary study
utilising a miRNA microarray analysis has found that miR-23b was
down-regulated in the regenerating rat liver tissues 120 h (h) afterFig. 5. Down-regulation of miR-23b may contribute to TGF-b1/Smad3 signalling pathway
Smad3 in the regenerating liver from 24 to 168 h after resection. (B) Protein expression o
was used as the loading control. (C) Mitotic and PCNA-positive hepatocytes following PH
were determined by counting apoptotic cells by TUNEL staining as described in the mate
magniﬁcation) from 24 to 168 h after PHx. (F) Caspase 3 activity from 24 to 168 h after PH
RFU (relative ﬂuorescence unit). All data were obtained from at least three independent70% PHx compared with that of the SH group. In the present study
we conﬁrmed that miR-23b is down-regulated during the termina-
tion stage of LR. Our study also found that down-regulation of miR-
23b inhibits cell proliferation, which may be attributed to G2/M ar-
rest by ﬂow cytometry investigation, as shown in Fig. 2. Therefore,
down-regulation of miR-23b may contribute to the termination of
LR, which is characterised by reduced proliferation and enhanced
cellular apoptosis.during the termination stage of LR. (A) mRNA expression as assessed by qRT-PCR of
f Smad3 and phosphorylated Smad3 in the regenerating liver from 24 to 168 h. Actin
were counted in triplicate using different sections. (D) Percentages of apoptotic cells
rial and methods section. (E) Liver sections were stained with PCNA or TUNEL (400
x. The relative content of activated caspase 3 enzyme in each sample is expressed as
experiments and are shown as the means ± S.E., ⁄P < 0.05, ⁄⁄P < 0.01.
Fig. 6. TGF-b1 inhibits the expression of miR-23b at the transcriptional level. (A) TGF-b1 treatment leads to decreases in the mRNA expression of miR-23b. Increasing
concentrations of TGF-b1 (0, 2, 4, 5 ng/ml) negatively correlate with miR-23b mRNA expression. Beta-actin was used as the loading control. (B) BRL-3A cells transfected with a
reporter vector containing the miR-23b promoter were treated with PBS or with TGF-b1 (5 ng/ml) for 24 h, and the luciferase activities were monitored using with pGL-3
basic and control vector as negative controls. The results are shown as the ratio of relative luciferase activities in TGF-b1-treated cells to PBS-treated cells. All data were
obtained from at least three independent experiments and are shown as the means ± S.E., ⁄P < 0.05, ⁄⁄P < 0.01.
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termination stage of LR, it is very important to identify the target
gene of miR-23b. Even though the nature of the ‘‘stop’’ signal for
the regenerative process is another area of uncertainty, strong evi-
dence has been presented on TGF-b1 and activin signal pathway
[18]. Therefore, we used a Molecular Annotation System (MAS) to
categorize all putative target genes of miR-23b predicted by Tar-
getscan. Interestingly, we identiﬁed Smad3, Smad4 and Smad5 in
TGF-b1 and activin pathway. In addition, a recent study has shown
that miR-23b served as a molecular switch in regulating Trans-
forming growth factor-b1 (TGF-b1) signaling by targeting Smads
(Smad3, Smad4 and Smad5) [15]. Therefore, we speculate miR-
23b may be involved in the termination of LR by targeting Smads.
Here, we showed that miR-23b not only inhibit Smad3 in a direct
way but also may result in the down-regulation of Smad3 in regen-
erating liver. Our study has conﬁrmed that Smad3 but not Smad4
or Smad5 is a putative target gene of miR-23b in livers following
PHx.
There is evidence that Smad3 plays a more signiﬁcant role in
the induction of TGF-b1-induced apoptosis than other Smads
downstream of TGF-b1. Over-expression of Smad3 greatly potenti-
ates the induction of apoptosis in response to TGF-b1, while
expression of a dominant-negative mutant of Smad3 inhibits
TGF-b1 induced apoptosis [20–22]. Therefore, we presume that
down-regulation of miR-23b may contribute to the termination
of LR by regulating TGF-b1 signaling pathway through targeting
smad3. To validate our assertion, ﬁrstly, we have investigated the
effect of miR-23b on TGF-b1 signalling in BRL-3A cells. Interest-
ingly, our results suggest that up-regulation of miR-23b could par-
tially inhibit TGF-b1-induced apoptosis in BRL-3A cells by reducing
the expression of Smad3. In addition, in the regenerating liver after
PHx, we have also found that when miR-23b was down-regulated
from 72 to 168 h after PHx, TGF-b1 downstream molecular Smad3
and phosphorylated Smad3 were up-regulated accompanied with
an enhanced apoptosis. Taken together, we can conclude that
down-regulation of miR-23b may contribute to activation of the
TGF-b1/Smad3 signalling pathway during the termination stage
of liver regeneration.
As to the relationship between TGF-b1 and miR-23b, we consid-
ered TGF-b1 as a possible upstream regulator of miR-23b. Firstly,
several reports have demonstrated that TGF-b1 can either posi-
tively or negatively regulate the expression of miRNAs including
miR-192 and miR-24 [23–25]. More interestingly, even in the pro-
cess of LR, miR-23b down-regulation occurs after 72 h PHx, when
TGF-b1 expression is at its highest levels [26–28]. In addition,
miR-23b can directly regulate the expression of Smad3 which isa downstream molecular in TGF-b1 signaling. Therefore, we pre-
sumed that miR-23b may act as a pitch point in the TGF-b1 signal-
ling pathway. In the present study, we have conﬁrmed that TGF-b1
can regulate the expression of miR-23b at the transcriptional level.
Our present ﬁndings suggest a TGF-b1-miR-23b-smad3 signaling
may act as a novel mechanism in the termination stage of LR.
In conclusion, miR-23b may contribute to TGF-b1/Smad3 sig-
naling pathway during the termination stage of LR. Our ﬁndings re-
veal a miRNA-mediated regulation pattern during the termination
stage of LR.Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2011.02.031.Reference
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